Study on Left Atrial Function of Paroxysmal Supraventricular Tachycardia After Radiofrequency Ablation
1 other identifier
interventional
100
1 country
1
Brief Summary
This study to investigate the effects of RF ablation on left atrial systolic function in patients with atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular tachycardia (AVRT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
November 16, 2017
CompletedFirst Posted
Study publicly available on registry
November 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedMarch 18, 2020
March 1, 2020
3.2 years
November 16, 2017
March 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Left Atrial Function of postoperative radiofrequency ablation.
1 month
Study Arms (2)
patients with atrioventricular nodal reentrant tachycardia
EXPERIMENTALradiofrequency catheter ablation therapy
patients with atrioventricular tachycardia
EXPERIMENTALradiofrequency catheter ablation therapy
Interventions
Eligibility Criteria
You may qualify if:
- Patients with paroxysmal supraventricular tachycardia,includes atrioventricular reentrant tachycardia and atrioventricular nodal reentrant tachycardia, Age is \>14 years
You may not qualify if:
- Atrial fibrillation, Atrial tachycardia, Structural heart disease, Ventricular arrhythmias, Patients with impaired left ventricular systolic function or on antiarrhythmics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruiqin xielead
Study Sites (1)
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- director of cardiology department
Study Record Dates
First Submitted
November 16, 2017
First Posted
November 20, 2017
Study Start
January 1, 2017
Primary Completion
March 1, 2020
Study Completion
March 1, 2020
Last Updated
March 18, 2020
Record last verified: 2020-03